Dr. Tom Cirrito is a serial entrepreneur, inventor, and founder of multiple companies in the life sciences. He is one of few biotechnology entrepreneurs in the industry who built a company from an early stage through an IPO, and led a drug development program from concept through FDA approval. He is Founder and CEO of Y2X Life Sciences, and Founder and Executive Chairman of Filament BioSolutions. Previously, he founded and was CEO of Biotagenics, Inc. and Immunovent, Inc., and helped to found AGelity BioMechanics, the first “Hospital for Special Surgery” start-up, also serving as the original CEO. He began his career in biotechnology as Vice President of Research and Development and Director of Business Development at Stemline Therapeutics (NASDAQ: STML). The inventor of numerous patent applications, he is currently a Director of Incysus Therapeutics.
Dr. Cirrito holds a B.A. in Biological Sciences and a Ph.D. in Immunology from Washington University (St. Louis, Missouri), with published works in a wide variety of scientific fields.